XENE - Xenon Pharmaceuticals Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$85.00
DETAILS
HIGH:
$100.00
LOW:
$60.00
MEDIAN:
$89.50
CONSENSUS:
$85.00
UPSIDE:
56.91%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 7.5 | 0 | 0 | 9.4 | 18.4 | 32.2 | 6.8 | 0 | 0.3 | 1.8 | 15.6 | 28.4 | 27.4 | 14.3 | 6.9 |
| Cost of Revenue | 2.5 | 2.6 | 167.5 | 0 | 0 | 0 | 0 | 6 | 25.6 | 1.1 | 2.8 | 5.9 | 6.2 | 7.3 | 0 |
| Gross Profit | 5.0 | (2.6) | (167.5) | 9.4 | 18.4 | 32.2 | 6.8 | (6) | (25.3) | 0.7 | 12.8 | 22.5 | 21.1 | 7.0 | 6.9 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 300.9 | 210.4 | 167.5 | 105.8 | 75.5 | 50.5 | 38.8 | 23.6 | 25.6 | 19.8 | 15.2 | 11.8 | 12.3 | 10.5 | 12.3 |
| SG&A Expenses | 79.6 | 68.9 | 46.5 | 32.8 | 22.0 | 12.9 | 10.8 | 8.4 | 7.3 | 6.8 | 9.8 | 5.5 | 5.3 | 7.0 | 6.7 |
| Other Expenses | (2.5) | (2.6) | (167.5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (6.4) | 0 | 0 | 0 | 0 |
| Operating Expenses | 378.0 | 276.7 | 46.5 | 138.6 | 97.4 | 63.5 | 49.6 | 32.0 | 32.9 | 26.6 | 24.9 | 17.3 | 17.6 | 17.5 | 19.0 |
| Operating Income | |||||||||||||||
| Operating Income | (373.1) | (279.3) | (214.1) | (129.1) | (79.0) | (31.3) | (42.8) | (38.0) | (32.6) | (24.8) | (9.4) | 11.1 | 9.7 | (3.2) | (12.1) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.5 | 1.4 | 1.4 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.1 |
| Interest Income | 26.8 | 41.9 | 27.6 | 8.7 | 0.5 | 2.3 | 2.4 | 1.2 | 0.5 | 0.5 | 0.5 | 0.6 | 0.3 | 0.1 | 0.2 |
| Profitability | |||||||||||||||
| EBITDA | (342.4) | (235.9) | (210.5) | (127.7) | (78.1) | (28.0) | (39.8) | (32.5) | (30.1) | (24.0) | (8.3) | 11.8 | 10.4 | (3.4) | (10.8) |
| EBIT | (344.9) | (238.4) | (214.1) | (129.1) | (79.0) | (28.6) | (40.2) | (33.1) | (30.7) | (24.8) | (9.4) | 11.1 | 9.7 | (4.2) | (11.9) |
| Income Before Tax | (344.9) | (238.4) | (182.7) | (125.3) | (78.9) | (29.1) | (41.6) | (34.5) | (30.7) | (23.0) | (15.8) | 13.0 | 12.0 | (4.3) | (12.0) |
| Income Tax Expense | 1.0 | (4.1) | (0.3) | 0.1 | (0.0) | (0.3) | (0.0) | 4.9 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 |
| Net Income | (345.9) | (234.3) | (182.4) | (125.4) | (78.9) | (28.8) | (41.6) | (34.5) | (30.7) | (23.0) | (15.8) | 13.0 | 12.0 | (4.3) | (12.0) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -4.36 | -3.01 | -2.73 | -2.06 | -1.77 | -0.83 | -1.54 | -1.78 | -1.71 | -1.48 | -1.10 | 0.94 | 0.42 | -3.23 | -9.02 |
| EPS (Diluted) | -4.36 | -3.01 | -2.73 | -2.06 | -1.77 | -0.83 | -1.54 | -1.78 | -1.71 | -1.48 | -1.10 | 0.94 | 0.39 | -3.23 | -9.02 |
| Shares Outstanding | 79.3 | 77.9 | 66.9 | 60.5 | 43.6 | 34.5 | 25.9 | 19.4 | 18.0 | 15.5 | 14.3 | 13.9 | 9.1 | 1.3 | 1.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 199.2 | 142.7 | 148.6 | 57.2 | 175.7 | 45.0 | 24.8 | 67.8 | 20.5 | 17.1 |
| Short-Term Investments | 349.7 | 484.2 | 489.4 | 534.8 | 376.1 | 132.0 | 116.6 | 51.6 | 23.2 | 47.1 |
| Net Receivables | 1.4 | 1.5 | 0.9 | 1.0 | 2.8 | 1.8 | 0.8 | 0.2 | 0.4 | 0.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 10.4 | 6.9 | 6.0 | 7.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 560.6 | 635.3 | 645.0 | 600.3 | 559.0 | 181.8 | 144.9 | 121.4 | 44.8 | 65.7 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 15.3 | 18.2 | 18.8 | 16.9 | 12.5 | 6.9 | 2.6 | 1.0 | 1.1 | 1.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 37.2 | 127.5 | 292.8 | 128.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.2 | 7.5 | 7.4 | 7.8 | 0 | 0 | 0 | (0.1) | 0.2 | 0.4 |
| Total Non-Current Assets | 421.0 | 162.9 | 319.8 | 153.8 | 13.0 | 7.4 | 2.8 | 1.0 | 1.3 | 1.8 |
| Total Assets | 981.7 | 798.1 | 964.8 | 754.1 | 572.0 | 189.2 | 147.7 | 122.4 | 46.1 | 67.5 |
| Current Liabilities | ||||||||||
| Account Payables | 3.9 | 5.1 | 8.6 | 8.5 | 3.8 | 3.0 | 2.5 | 0.7 | 1.3 | 1.5 |
| Short-Term Debt | 1.5 | 0 | 0 | 0 | 0 | 0 | 4.7 | 0 | 0.7 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 3.6 | 29.7 | (15.0) | 0 | 0 |
| Other Current Liabilities | 21.6 | 9.9 | 0.3 | 5.8 | 5.9 | 2.9 | 3.5 | 1.7 | 0.0 | 0.1 |
| Total Current Liabilities | 41.8 | 35.6 | 27.3 | 22.7 | 14.3 | 14.8 | 43.4 | 4.1 | 4.1 | 3.5 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 10.9 | 15.0 | 6.1 | 0 |
| Deferred Tax Liabilities | 348.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 358.1 | 7.6 | 9.6 | 9.9 | 7.7 | 3.0 | 12.3 | 15.0 | 6.1 | 0.1 |
| Total Liabilities | 399.9 | 43.2 | 36.9 | 32.6 | 22.0 | 17.8 | 55.7 | 19.1 | 10.2 | 3.6 |
| Stockholders' Equity | ||||||||||
| Common Stock | 1,598.6 | 1,456.8 | 1,436.4 | 1,065.1 | 783.2 | 397.7 | 294.2 | 265.9 | 173.8 | 173.2 |
| Retained Earnings | (1,245.4) | (899.5) | (665.1) | (482.7) | (357.4) | (278.5) | (249.7) | (207.9) | (173.4) | (142.7) |
| Accumulated Other Comprehensive Income | 0.3 | (1.6) | (0.1) | (3) | (1.0) | (1.0) | (1.0) | (1.0) | (1.0) | (1.0) |
| Total Stockholders' Equity | 581.8 | 754.9 | 927.9 | 721.5 | 550.0 | 171.4 | 92.0 | 103.3 | 35.9 | 63.9 |
| Total Liabilities & Equity | 981.7 | 798.1 | 964.8 | 754.1 | 572.0 | 189.2 | 147.7 | 122.4 | 46.1 | 67.5 |
| Debt Metrics | ||||||||||
| Total Debt | 7.9 | 9.0 | 10.9 | 10.4 | 8.3 | 3.3 | 16.4 | 15.0 | 6.8 | 0 |
| Net Debt | (191.2) | (133.7) | (137.7) | (46.8) | (167.4) | (41.7) | (8.3) | (52.7) | (13.7) | (17.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (345.9) | (234.3) | (182.4) | (125.4) | (78.9) | (28.8) | (41.6) | (34.5) | (30.7) | (23.0) |
| Depreciation & Amortization | 2.5 | 2.6 | 3.5 | 1.6 | 0.9 | 0.6 | 0.4 | 0.6 | 0.6 | 0.9 |
| Stock-Based Compensation | 53.7 | 50.7 | 32.4 | 20.4 | 10.0 | 5.7 | 2.9 | 2.6 | 2.2 | 2.2 |
| Change in Working Capital | 4.4 | 5.7 | 5.6 | (0.7) | (2.6) | (26.1) | 33.5 | 0.0 | 0.6 | 1.8 |
| Other Non-Cash Items | 9.4 | 2.8 | (4.2) | 5.7 | 1.0 | 0.8 | 0.2 | (4.1) | 0.0 | (0.1) |
| Operating Cash Flow | (279.1) | (181.4) | (145.3) | (98.4) | (69.5) | (48.1) | (4.6) | (34.7) | (28.7) | (19.6) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.8) | (3.1) | (5.6) | (2.9) | (2.0) | (2.6) | (1.2) | (0.5) | (0.3) | (0.3) |
| Acquisitions | 0 | 0 | 0 | 296.0 | (144.8) | (214.7) | (75.4) | (48.5) | (52.6) | 0 |
| Purchases of Investments | (355.7) | (532.3) | (793.9) | (551.1) | (389.5) | (228.9) | (140.5) | (77.0) | (28.0) | (47.6) |
| Sales/Maturities of Investments | 574.5 | 700.3 | 682.4 | 258.0 | 144.8 | 214.7 | 75.4 | 48.5 | 52.6 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (296.0) | 144.8 | 214.7 | 75.4 | 48.5 | 52.6 | (47.6) |
| Investing Cash Flow | 218.0 | 165 | (117.2) | (296.0) | (246.8) | (16.8) | (66.3) | (29.0) | 24.3 | (47.8) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | (16.7) | 0 | 8.5 | 6.9 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0.0 | 0.0 | 0.7 | 0.3 | 0.1 | 0.1 | 0.3 | 0.2 | 0.1 |
| Financing Cash Flow | 117.1 | 12.1 | 353.5 | 278.5 | 447.5 | 85.8 | 27.5 | 111.6 | 7.1 | 24.0 |
| Cash Position | ||||||||||
| Net Change in Cash | 56.5 | (5.9) | 91.4 | (118.4) | 130.7 | 20.3 | (43.0) | 47.3 | 3.4 | (41.6) |
| Cash at Beginning | 142.7 | 148.6 | 57.2 | 175.7 | 45.0 | 24.8 | 67.8 | 20.5 | 17.1 | 58.7 |
| Cash at End | 199.2 | 142.7 | 148.6 | 57.2 | 175.7 | 45.0 | 24.8 | 67.8 | 20.5 | 17.1 |
| Free Cash Flow | (279.9) | (184.5) | (150.9) | (101.3) | (71.6) | (50.8) | (5.9) | (35.2) | (29.0) | (19.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 7.5 | 0 | 0 | 9.4 | 18.4 | 32.2 | 6.8 | 0 | 0.3 | 1.8 | 15.6 | 28.4 | 27.4 | 14.3 | 6.9 |
| Gross Profit | 5.0 | (2.6) | (167.5) | 9.4 | 18.4 | 32.2 | 6.8 | (6) | (25.3) | 0.7 | 12.8 | 22.5 | 21.1 | 7.0 | 6.9 |
| Operating Income | (373.1) | (279.3) | (214.1) | (129.1) | (79.0) | (31.3) | (42.8) | (38.0) | (32.6) | (24.8) | (9.4) | 11.1 | 9.7 | (3.2) | (12.1) |
| Net Income | (345.9) | (234.3) | (182.4) | (125.4) | (78.9) | (28.8) | (41.6) | (34.5) | (30.7) | (23.0) | (15.8) | 13.0 | 12.0 | (4.3) | (12.0) |
| EPS (Diluted) | -4.36 | -3.01 | -2.73 | -2.06 | -1.77 | -0.83 | -1.54 | -1.78 | -1.71 | -1.48 | -1.10 | 0.94 | 0.39 | -3.23 | -9.02 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 199.2 | 142.7 | 148.6 | 57.2 | 175.7 | 45.0 | 24.8 | 67.8 | 20.5 | 17.1 | |||||
| Total Assets | 981.7 | 798.1 | 964.8 | 754.1 | 572.0 | 189.2 | 147.7 | 122.4 | 46.1 | 67.5 | |||||
| Total Debt | 7.9 | 9.0 | 10.9 | 10.4 | 8.3 | 3.3 | 16.4 | 15.0 | 6.8 | 0 | |||||
| Stockholders' Equity | 581.8 | 754.9 | 927.9 | 721.5 | 550.0 | 171.4 | 92.0 | 103.3 | 35.9 | 63.9 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (279.1) | (181.4) | (145.3) | (98.4) | (69.5) | (48.1) | (4.6) | (34.7) | (28.7) | (19.6) | |||||
| Capital Expenditure | (0.8) | (3.1) | (5.6) | (2.9) | (2.0) | (2.6) | (1.2) | (0.5) | (0.3) | (0.3) | |||||
| Free Cash Flow | (279.9) | (184.5) | (150.9) | (101.3) | (71.6) | (50.8) | (5.9) | (35.2) | (29.0) | (19.8) | |||||